Immunotherapy (NK Cells)
Natural Killer (NK) cells are cytotoxic lymphocytes that form a critical component of the innate immune system. They provide rapid immune responses against virus-infected cells and malignant transformation without prior antigen sensitization.
NK cells identify stressed or abnormal cells through reduced or absent expression of Major Histocompatibility Complex class I (MHC I) molecules, a mechanism known as “missing-self” recognition.
NK cell therapy is being explored for hematological malignancies, solid tumors, viral infections, and immune dysfunctions. It is often integrated with conventional cancer therapies to enhance clinical outcomes.
NK cell products are manufactured under controlled conditions with validated expansion, activation, and safety testing protocols.